Title : Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.

Pub. Date : 1987 Dec 15

PMID : 3677090






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Since estrogen is a well documented mitogen of estrogen-responsive human breast cancer (HBC) cells, we studied the influence of estradiol and its antagonist tamoxifen on the expression of c-myc in HBC cell lines. Tamoxifen MYC proto-oncogene, bHLH transcription factor Homo sapiens
2 In the ER+ cell lines the addition of estradiol resulted in a noticeable increase in c-myc expression after 15 min with a maximal (greater than 10-fold) induction in 1-2 h. In the ER- cell lines the level of c-myc mRNA was high and was unaffected by estrogen or tamoxifen; in the ER- cancer cell lines, neither amplification nor rearrangement of the c-myc gene was observed. Tamoxifen MYC proto-oncogene, bHLH transcription factor Homo sapiens
3 In the ER+ cell lines the addition of estradiol resulted in a noticeable increase in c-myc expression after 15 min with a maximal (greater than 10-fold) induction in 1-2 h. In the ER- cell lines the level of c-myc mRNA was high and was unaffected by estrogen or tamoxifen; in the ER- cancer cell lines, neither amplification nor rearrangement of the c-myc gene was observed. Tamoxifen MYC proto-oncogene, bHLH transcription factor Homo sapiens
4 In the ER+ cell lines the addition of estradiol resulted in a noticeable increase in c-myc expression after 15 min with a maximal (greater than 10-fold) induction in 1-2 h. In the ER- cell lines the level of c-myc mRNA was high and was unaffected by estrogen or tamoxifen; in the ER- cancer cell lines, neither amplification nor rearrangement of the c-myc gene was observed. Tamoxifen MYC proto-oncogene, bHLH transcription factor Homo sapiens